Publication Information

{'id': 'https://openalex.org/W4282977391', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-5385', 'title': 'Abstract 5385: Multiple modes of action of the CD38 x ICAM-1 bispecific antibody', 'display_name': 'Abstract 5385: Multiple modes of action of the CD38 x ICAM-1 bispecific antibody', 'publication_year': 2022, 'publication_date': '2022-06-15', 'ids': {'openalex': 'https://openalex.org/W4282977391', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-5385'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-5385', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5043234638', 'display_name': 'Xiaocheng Chen', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Xiaocheng Chen', 'raw_affiliation_strings': ['1Virtuoso Therapeutics, San Mateo, CA.'], 'affiliations': [{'raw_affiliation_string': '1Virtuoso Therapeutics, San Mateo, CA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014733163', 'display_name': 'Oi Kwan Wong', 'orcid': 'https://orcid.org/0009-0003-1185-9339'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Oi Kwan Wong', 'raw_affiliation_strings': ['1Virtuoso Therapeutics, San Mateo, CA.'], 'affiliations': [{'raw_affiliation_string': '1Virtuoso Therapeutics, San Mateo, CA.', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5085037854', 'display_name': 'Leonard Post', 'orcid': 'https://orcid.org/0009-0007-5779-4146'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Leonard Post', 'raw_affiliation_strings': ['1Virtuoso Therapeutics, San Mateo, CA.'], 'affiliations': [{'raw_affiliation_string': '1Virtuoso Therapeutics, San Mateo, CA.', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.449, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.707371, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 70, 'max': 76}, 'biblio': {'volume': '82', 'issue': '12_Supplement', 'first_page': '5385', 'last_page': '5385'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10602', 'display_name': 'Glycosylation and Glycoproteins Research', 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/daratumumab', 'display_name': 'Daratumumab', 'score': 0.49479502}], 'concepts': [{'id': 'https://openalex.org/C40677261', 'wikidata': 'https://www.wikidata.org/wiki/Q21418091', 'display_name': 'Antibody-dependent cell-mediated cytotoxicity', 'level': 4, 'score': 0.84576166}, {'id': 'https://openalex.org/C159912055', 'wikidata': 'https://www.wikidata.org/wiki/Q14885119', 'display_name': 'CD38', 'level': 4, 'score': 0.7566936}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.70184}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.58976597}, {'id': 'https://openalex.org/C542903549', 'wikidata': 'https://www.wikidata.org/wiki/Q422248', 'display_name': 'Monoclonal antibody', 'level': 3, 'score': 0.57597303}, {'id': 'https://openalex.org/C147483822', 'wikidata': 'https://www.wikidata.org/wiki/Q103537', 'display_name': 'Antigen', 'level': 2, 'score': 0.5658025}, {'id': 'https://openalex.org/C2781119759', 'wikidata': 'https://www.wikidata.org/wiki/Q5222113', 'display_name': 'Daratumumab', 'level': 4, 'score': 0.49479502}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.47463498}, {'id': 'https://openalex.org/C2779338263', 'wikidata': 'https://www.wikidata.org/wiki/Q208414', 'display_name': 'Lymphoma', 'level': 2, 'score': 0.43924883}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.40152508}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.39242506}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.33197677}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.26950562}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.10118657}, {'id': 'https://openalex.org/C28328180', 'wikidata': 'https://www.wikidata.org/wiki/Q48196', 'display_name': 'Stem cell', 'level': 2, 'score': 0.08792606}, {'id': 'https://openalex.org/C10205521', 'wikidata': 'https://www.wikidata.org/wiki/Q4035578', 'display_name': 'CD34', 'level': 3, 'score': 0.06988126}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-5385', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.82}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4362410946', 'https://openalex.org/W4361951970', 'https://openalex.org/W4361945426', 'https://openalex.org/W4361920796', 'https://openalex.org/W3114387189', 'https://openalex.org/W3031449964', 'https://openalex.org/W2986658406', 'https://openalex.org/W2980754686', 'https://openalex.org/W2980731506', 'https://openalex.org/W2764340845'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1, 47], 'cluster': [2], 'of': [3, 35, 49, 57, 122, 194, 203, 214, 223, 290, 309, 311, 321], 'differentiation': [4], '38': [5], '(CD38)': [6], 'is': [7, 63, 112], 'a': [8, 32, 87, 91, 120, 211, 221], 'well': [9, 71], 'validated': [10], 'target': [11, 79], 'for': [12, 292, 325], 'treating': [13, 293], 'multiple': [14, 30, 116, 288, 296], 'myeloma.': [15, 297], 'Although': [16], 'the': [17, 173, 195, 201, 244, 255, 261, 312, 322], 'anti-CD38': [18], 'monoclonal': [19], 'antibody': [20, 89, 246, 266, 286, 317], 'treatment': [21], 'has': [22, 51, 177, 287], 'resulted': [23], 'in': [24, 27, 115, 139, 272], 'outstanding': [25], 'responses': [26], 'patients': [28, 36, 44], 'with': [29, 55, 149, 163, 220, 235], 'myeloma,': [31, 117], 'significant': [33], 'portion': [34], 'still': [37], 'failed': [38], 'to': [39, 165, 254], 'respond': [40], 'and': [41, 97, 103, 119, 152, 154, 180, 216, 225, 250, 275, 295], 'nearly': [42], 'all': [43], 'eventually': [45], 'relapsed.': [46], 'mechanism': [48], 'resistance': [50], 'been': [52], 'partially': [53], 'associated': [54, 93], 'downregulation': [56], 'CD38': [58, 62, 80, 98, 145, 167, 224, 238, 257, 262, 282, 313], 'expression.': [59, 168, 239], 'In': [60], 'addition,': [61], 'broadly': [64], 'expressed': [65, 114], 'on': [66, 81, 159, 183, 210, 233], 'normal': [67], 'lymphoid,': [68], 'myeloid,': [69], 'as': [70, 72], 'red': [73], 'blood': [74], 'cells': [75, 162, 234], '(RBCs).': [76], 'To': [77, 198], 'effectively': [78], 'tumor': [82, 92, 101, 161, 269], 'cells,': [83], 'we': [84, 206, 241], 'hypothesize': [85], 'that': [86, 172, 243, 281], 'bispecific': [88, 144, 196, 245, 265, 285, 316], 'against': [90, 126], 'guide': [94], 'antigen': [95, 204], '(TAG)': [96], 'could': [99], 'achieve': [100], 'specificity': [102], 'improve': [104], 'potency.': [105], 'ICAM-1,': [106, 127], 'an': [107], 'Ig-like': [108], 'cell': [109, 218], 'adhesion': [110], 'molecule,': [111], 'highly': [113], 'lymphoma': [118, 217, 276, 294], 'subset': [121], 'solid': [123], 'tumors.': [124], 'Antibody': [125], 'bersanlimab': [128], '(BI505,': [129], 'BioInvent),': [130], 'was': [131], 'well-tolerated,': [132], 'but': [133], 'only': [134], 'showed': [135, 171, 242], 'limited': [136], 'clinical': [137], 'efficacy': [138], 'MM': [140], 'patients.': [141], 'We': [142, 228], 'generated': [143], 'x': [146, 263, 283, 314], 'ICAM-1': [147, 226, 284, 315], 'antibodies': [148], 'different': [150], 'formats': [151], 'geometries': [153], 'compared': [155], 'their': [156], 'in-vitro': [157], 'activities': [158, 182, 193, 209, 271], 'ICAM1high': [160], 'low': [164, 237], 'medium': [166], 'Our': [169], 'results': [170], 'asymmetric': [174], '1+1': [175], 'format': [176], 'potent': [178, 268], 'ADCC': [179, 192, 208, 231], 'ADCP': [181], 'ICAM-1+CD38medium': [184], 'or': [185], 'ICAM-1+CD38low': [186], 'cells.': [187], 'Fc': [188], 'modifications': [189], 'further': [190, 199], 'improved': [191], 'antibody.': [197, 258], 'understand': [200], 'impact': [202], 'densities,': [205], 'tested': [207], 'selected': [212], 'set': [213], 'myeloma': [215, 274], 'lines': [219], 'range': [222], 'expressions.': [227], 'observed': [229], 'superior': [230], 'activity': [232], 'extremely': [236], 'Moreover,': [240], 'reduced': [247], 'NK': [248], 'fratricide': [249], 'RBC': [251], 'binding': [252], 'comparing': [253], 'bivalent': [256], 'Most': [259], 'importantly,': [260], 'ICAM1': [264], 'demonstrated': [267], 'inhibition': [270], 'in-vivo': [273], 'models.': [277], 'These': [278], 'studies': [279], 'suggested': [280], 'modes': [289, 308], 'action': [291, 310], 'Citation': [298], 'Format:': [299], 'Xiaocheng': [300], 'Chen,': [301], 'Oi': [302], 'Kwan': [303], 'Wong,': [304], 'Leonard': [305], 'Post.': [306], 'Multiple': [307], '[abstract].': [318], 'In:': [319], 'Proceedings': [320], 'American': [323], 'Association': [324], 'Cancer': [326, 337], 'Research': [327], 'Annual': [328], 'Meeting': [329], '2022;': [330], '2022': [331], 'Apr': [332], '8-13.': [333], 'Philadelphia': [334], '(PA):': [335], 'AACR;': [336], 'Res': [338], '2022;82(12_Suppl):Abstract': [339], 'nr': [340], '5385.': [341]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4282977391', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}], 'updated_date': '2024-12-24T04:33:34.676281', 'created_date': '2022-06-17'}